| --- | --- | --- | --- | --- | --- | |-----------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | Investor Presentation | | | | | | | NOVEMBER 2024 | | | | | | DISCLAIMER This presentation contains and related discussions may contain "forward-looking statements" within the meaning of U.S. federal securities laws. Forward-looking statements include information concerning possible or assumed future results of operations, Rocket Companies, Inc.'s (the "Company" ...

| --- | --- | |------------------------------------------------|-------| | | | | | | | | | | Investor Overview Q3 2024 Financial Results | | | November 12, 2024 DATE | | Q3 2024 EARNINGS CALL > SAFE HARBOR STATEMENT Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statement ...

IAS= Q3 2024 INVESTOR PRESENTATION DISCLAIMER Important Information About This Presentation This presentation is for informational purposes and does not constitute an offer to sell, a solicitation to buy, or a recommendation to purchase any equity, debt or other financial instruments of Integral Ad Science Holding Corp. ("IAS," "we," "us," or the "Company") or any of its affiliates. The listing of customers and associated marks provided in this presentation are meant to represent a sampling of customers tha ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-----------------------------|-------|-------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | Third Quarter 2024 Earnings | | | | | | | | | | | | Conference Call November 12, 2024 | | | | | | | | | | | | | | | | | | | | | | | | | IMPORTANT NOTICES Forward-looking Statements. During the presentation, any comments made about future plans, events, financial results, performance, ...

Q3 2024 Disclaimer 2 Forward-Looking Statements This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services; and other statements identified by words such as "will likely result," "are expected to," "will continue," "is antic ...

| --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Theravance Bio ...

Crescent Capital BDC, Inc. Quarterly Earnings Presentation September 30, 2024 Disclaimer and Forward-Looking Statement 2 This presentation (the "Presentation") has been prepared by Crescent Capital BDC, Inc. (together with its consolidated subsidiaries, "CCAP," "Crescent BDC" or the "Company") and may be used for informational purposes only. This Presentation contains summaries of certain financial and statistical information about the Company and should be viewed in conjunction with the Company's most rece ...

Rackspace Technology Q3 2024 Earnings Presentation November 12, 2024 2 Disclaimer Forward-Looking Statements Rackspace Technology has made statements in this presentation and other reports, filings, and other public written and verbal announcements that are forward-looking and therefore subject to risks and uncertainties. All statements, other than statements of historical fact, included in this presentation are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigati ...

Supplemental Financial Information For the quarter ended September 30, 2024 November 12, 2024 Corporate Profile And Disclosures Regarding Non-GAAP Financial Measures 2 Comparable Corporate Financial Information 6 Capitalization 12 Property-Level Data And Operating Statistics 15 Property-Level Revenues, Adjusted EBITDAre & Adjusted EBITDAre Margins 20 Supplemental Financial Information November 12, 2024 Table of Contents Supplemental Financial Information November 12, 2024 CORPORATE PROFILE AND DISCLOSURES R ...

9M and Q3 2024 Results Conference call and webcast for investors and analysts 12 November 2024 Forward-looking statements In order, among other things, to utilise the 'safe harbour' provisions of the US Private Securities Litigation Reform Act of 1995, AstraZeneca (hereafter 'the Group') provides the following cautionary statement: This document contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group, including, among other things, stateme ...